SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000882104-20-000046
Filing Date
2020-04-07
Accepted
2020-04-07 08:47:20
Documents
1
Period of Report
2020-01-08

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_158626362264371.html 4/A  
1 FORM 4/A wf-form4a_158626362264371.xml 4/A 3604
  Complete submission text file 0000882104-20-000046.txt   5098
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALEXION PHARMACEUTICALS, INC. 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Monnet Dominique (Reporting) CIK: 0001632798 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-19756 | Film No.: 20778502